It has also been found that regenerating family member (REG4) is highly expressed in KRAS-mutant lung adenocarcinoma, and that silencing REG4 can inhibit cancer cell proliferation and genesis, making it a potential therapeutic target [130]. This evidence concerns the gene KRAS and cancer.